"This is about starting the data story at the source," said Charles Hutka, Chief Commercial Officer at StafaCT. "When apheresis data is captured directly -- across both collection and therapeutic ...
Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...
May 23 (UPI) --A new treatment might be able to remove "bad cholesterol" from the blood in a matter of hours, a recent study says. Within two to three hours, a procedure known as LDL apheresis drove ...
ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Chicago, Feb. 06, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global apheresis market was valued at US$ 3,248.3 million in 2023 and is projected to attain a valuation ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global therapeutic apheresis market is projected to grow from US$3.2 billion in 2026 to US$3.9 billion by 2033, at a CAGR of 2.7%. Therapeutic apheresis ...